GC
AHCO icon

Guggenheim Capital’s AdaptHealth AHCO Stock Holding History

Guggenheim Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201K Sell
16,898
-48,047
-74% -$492K ﹤0.01% 1525
2025
Q4 		$647K Buy
64,945
+50,517
+350% +$482K ﹤0.01% 1156
2025
Q3 		$129K Buy
14,428
+443
+3% +$4.1K ﹤0.01% 1543
2025
Q2 		$132K Sell
13,985
-944
-6% -$8.33K ﹤0.01% 1543
2025
Q1 		$162K Sell
14,929
-1,684
-10% -$16.9K ﹤0.01% 1560
2024
Q4 		$158K Buy
16,613
+1,525
+10% +$15.4K ﹤0.01% 1622
2024
Q3 		$169K Buy
15,088
+935
+7% +$9.94K ﹤0.01% 1795
2024
Q2 		$142K Buy
14,153
+1,432
+11% +$14.6K ﹤0.01% 1798
2024
Q1 		$146K Sell
12,721
-2,891
-19% -$24.6K ﹤0.01% 1824
2023
Q4 		$114K Buy
+15,612
New +$123K ﹤0.01% 1846

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guggenheim Capital's AHCO Position: Q1 2026 in Review

Guggenheim Capital reduced its AdaptHealth (AHCO) stake by 74% in Q1 2026, selling an estimated $492K and leaving 16,898 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Guggenheim Capital first reported a position in AHCO in Q4 2023 and has held it in 10 quarters since. The position peaked at $647K in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Guggenheim Capital held 16,898 shares of AdaptHealth worth $201K as of Q1 2026.
  • Guggenheim Capital sold 48,047 AdaptHealth shares in Q1 2026, an estimated $492K.
  • AdaptHealth made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1525 holding.
  • Guggenheim Capital first reported a position in AdaptHealth in Q4 2023 and has held it in 10 quarters since.
  • Guggenheim Capital's AdaptHealth position peaked at $647K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.